✦ LIBER ✦

Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease

✍ Scribed by Corey A. Siegel; L. Campbell Levy; Todd A. MacKenzie; Bruce E. Sands

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 360 KB
Volume: 14
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20283

No coin nor oath required. For personal study only.

✦ Synopsis

Background: For a patient to make informed, preference based decisions, they must be able to balance the risks and benefits of treatment. The aim of this study was to determine patients' and parents' perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease (IBD).

Methods: Adult patients with IBD and parents of patients attending IBD patient education symposiums were asked to complete a questionnaire regarding the risks and benefits of infliximab.

📜 SIMILAR VOLUMES

Successful treatment with infliximab of

Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases

✍ Andrea Cocco; Erika Angelucci; Angelo Viscido; Renzo Caprilli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

Lost in translation: Helping patients un

Lost in translation: Helping patients understand the risks of inflammatory bowel disease therapy

✍ Corey A. Siegel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Patients with inflammatory bowel disease are commonly treated with immunomodulators and biologic therapy. These treatments can be very effective, but are associated with risks of adverse events that need to be discussed with patients. Effectively communicating risks of therapy can be challenging bas

Adjustment to inflammatory bowel disease

Adjustment to inflammatory bowel disease: The relative influence of illness perceptions and coping

✍ Angela Dorrian; Martin Dempster; Pauline Adair 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Background: The Common Sense Model (CSM) of illness representations was used in the current study to examine the relative contribution of illness perceptions and coping strategies in explaining adjustment to inflammatory bowel disease (IBD). Methods: Participants were 80 adults consecutively at

5-Aminosalicylic acid therapy and the ri

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

✍ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective

MR colonography without bowel purgation

MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: Diagnostic accuracy and patient acceptance

✍ Jost Langhorst; Christiane A. Kühle; Waleed Ajaj; Michael Nüfer; Jörg Barkhausen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Background: The purpose of this pilot study was to assess the diagnostic accuracy of MR colonography (MRC) without bowel cleansing regarding its ability to quantify inflammatory bowel disease (IBD). In addition, patient acceptance was compared with conventional colonoscopy (CC). ## Methods: In

Safety of immunomodulators and biologics

Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding

✍ Javier P. Gisbert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

The aim of this article is to critically review available data regarding the safety of immunomodulators and biological therapies during pregnancy and breast-feeding in women with inflammatory bowel disease. Methotrexate and thalidomide can cause congenital anomalies and are contraindicated during pr